Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 21584692)

1.

Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies.

Dall'era M, Chakravarty EF.

Curr Rheumatol Rep. 2011 Aug;13(4):308-16. doi: 10.1007/s11926-011-0186-6. Review.

2.

[Treatment of systemic lupus erythematosus: myths, certainties and doubts].

Ruiz-Irastorza G, Danza A, Khamashta M.

Med Clin (Barc). 2013 Dec 21;141(12):533-42. doi: 10.1016/j.medcli.2013.02.014. Epub 2013 Apr 23. Review. Spanish.

PMID:
23622892
3.

The biology behind the new therapies for SLE.

Ermann J, Bermas BL.

Int J Clin Pract. 2007 Dec;61(12):2113-9. Review.

PMID:
17997810
4.

New developments in the treatment of systemic lupus erythematosus.

Tullus K.

Pediatr Nephrol. 2012 May;27(5):727-32. doi: 10.1007/s00467-011-1859-0. Epub 2011 Apr 26. Review.

PMID:
21516516
5.

Systemic lupus erythematosus: an update on current pharmacotherapy and future directions.

Touma Z, Urowitz MB, Gladman DD.

Expert Opin Biol Ther. 2013 May;13(5):723-37. doi: 10.1517/14712598.2013.764411. Epub 2013 Jan 23. Review.

PMID:
23339281
6.

Current and novel therapeutics in the treatment of systemic lupus erythematosus.

Yildirim-Toruner C, Diamond B.

J Allergy Clin Immunol. 2011 Feb;127(2):303-12; quiz 313-4. doi: 10.1016/j.jaci.2010.12.1087. Review.

7.

[What's new in internal medicine: emerging treatments for systemic lupus erythematosus].

Hachulla É.

Ann Dermatol Venereol. 2011 Dec;138 Suppl 4:S241-4. doi: 10.1016/S0151-9638(11)70097-7. Review. French.

PMID:
22202645
8.

B-cell targeted therapies in systemic lupus erythematosus: successes and challenges.

Harvey PR, Gordon C.

BioDrugs. 2013 Apr;27(2):85-95. doi: 10.1007/s40259-013-0015-8.

PMID:
23456653
9.

Belimumab: review of use in systemic lupus erythematosus.

Boyce EG, Fusco BE.

Clin Ther. 2012 May;34(5):1006-22. doi: 10.1016/j.clinthera.2012.02.028. Epub 2012 Mar 30. Review.

PMID:
22464040
10.

Biologics in SLE: towards new approaches.

van Vollenhoven RF, Parodis I, Levitsky A.

Best Pract Res Clin Rheumatol. 2013 Jun;27(3):341-9. doi: 10.1016/j.berh.2013.07.006. Review.

PMID:
24238691
11.

The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus.

Galarza-Maldonado C, Kourilovitch MR, Molineros JE, Cardiel MH, Zurita L, Soroka NF, Yagur VY, Doukh N, Cervera R.

Autoimmun Rev. 2010 Dec;10(2):108-11. doi: 10.1016/j.autrev.2010.08.012. Epub 2010 Sep 8.

PMID:
20804861
12.

B-cell-targeted therapy for systemic lupus erythematosus.

Sabahi R, Anolik JH.

Drugs. 2006;66(15):1933-48.

PMID:
17100405
13.

Update on the use of biologics in lupus.

Relan M, Vishwanath S, Shen L, Ambrus JL Jr.

Curr Pharm Biotechnol. 2014;15(6):516-20. Review.

PMID:
25091119
14.

Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE.

Dooley MA, Houssiau F, Aranow C, D'Cruz DP, Askanase A, Roth DA, Zhong ZJ, Cooper S, Freimuth WW, Ginzler EM; BLISS-52 and -76 Study Groups.

Lupus. 2013 Jan;22(1):63-72. doi: 10.1177/0961203312465781.

PMID:
23263865
15.

Systemic lupus erythematosus in 2013. Taking a closer look at biologic therapy for SLE.

Isenberg DA, Rahman A.

Nat Rev Rheumatol. 2014 Feb;10(2):71-2. doi: 10.1038/nrrheum.2013.203. Epub 2013 Dec 17. Review.

PMID:
24342984
16.

B-cell targeted treatments for lupus: the journey counts as much as the destination.

Falgarone G, Dhote R, Boissier MC.

Joint Bone Spine. 2012 Oct;79(5):437-40. doi: 10.1016/j.jbspin.2012.02.010. Epub 2012 Apr 4. Review.

PMID:
22480746
17.

Biologic therapy for systemic lupus erythematosus.

Dall'Era M, Wofsy D.

Discov Med. 2010 Jan;9(44):20-3. Review.

18.

Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.

Petri MA, van Vollenhoven RF, Buyon J, Levy RA, Navarra SV, Cervera R, Zhong ZJ, Freimuth WW; BLISS-52 and BLISS-76 Study Groups.

Arthritis Rheum. 2013 Aug;65(8):2143-53. doi: 10.1002/art.37995.

19.

[Biological therapies in systemic lupus erythematosus].

Suszek D, Jeleniewicz R, Majdan M.

Postepy Hig Med Dosw (Online). 2012 Aug 22;66:568-73. Review. Polish.

20.

Re-evaluation of biologic therapies in systemic lupus erythematosus.

Bruce IN.

Curr Opin Rheumatol. 2010 May;22(3):273-7. doi: 10.1097/BOR.0b013e3283374e78. Review.

PMID:
20177385
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk